These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
232 related articles for article (PubMed ID: 24204923)
1. Low-bone-mass phenotype of deficient mice for the cluster of differentiation 36 (CD36). Kevorkova O; Martineau C; Martin-Falstrault L; Sanchez-Dardon J; Brissette L; Moreau R PLoS One; 2013; 8(10):e77701. PubMed ID: 24204923 [TBL] [Abstract][Full Text] [Related]
2. Suberoylanilide hydroxamic acid (SAHA; vorinostat) causes bone loss by inhibiting immature osteoblasts. McGee-Lawrence ME; McCleary-Wheeler AL; Secreto FJ; Razidlo DF; Zhang M; Stensgard BA; Li X; Stein GS; Lian JB; Westendorf JJ Bone; 2011 May; 48(5):1117-26. PubMed ID: 21255693 [TBL] [Abstract][Full Text] [Related]
3. Reduced trabecular bone mass and strength in mice overexpressing Gα11 protein in cells of the osteoblast lineage. Dela Cruz A; Mattocks M; Sugamori KS; Grynpas MD; Mitchell J Bone; 2014 Feb; 59():211-22. PubMed ID: 24308950 [TBL] [Abstract][Full Text] [Related]
4. Conditional disruption of Pkd1 in osteoblasts results in osteopenia due to direct impairment of bone formation. Xiao Z; Zhang S; Cao L; Qiu N; David V; Quarles LD J Biol Chem; 2010 Jan; 285(2):1177-87. PubMed ID: 19887454 [TBL] [Abstract][Full Text] [Related]
5. Osteoblast-targeted overexpression of TAZ increases bone mass in vivo. Yang JY; Cho SW; An JH; Jung JY; Kim SW; Kim SY; Kim JE; Shin CS PLoS One; 2013; 8(2):e56585. PubMed ID: 23441207 [TBL] [Abstract][Full Text] [Related]
6. Gender- and region-specific alterations in bone metabolism in Scarb1-null female mice. Martineau C; Martin-Falstrault L; Brissette L; Moreau R J Endocrinol; 2014 Aug; 222(2):277-88. PubMed ID: 24928939 [TBL] [Abstract][Full Text] [Related]
7. Osteoblast-Specific Overexpression of Human WNT16 Increases Both Cortical and Trabecular Bone Mass and Structure in Mice. Alam I; Alkhouli M; Gerard-O'Riley RL; Wright WB; Acton D; Gray AK; Patel B; Reilly AM; Lim KE; Robling AG; Econs MJ Endocrinology; 2016 Feb; 157(2):722-36. PubMed ID: 26584014 [TBL] [Abstract][Full Text] [Related]
8. The atherogenic Scarb1 null mouse model shows a high bone mass phenotype. Martineau C; Martin-Falstrault L; Brissette L; Moreau R Am J Physiol Endocrinol Metab; 2014 Jan; 306(1):E48-57. PubMed ID: 24253048 [TBL] [Abstract][Full Text] [Related]
9. Runt-related transcription factor 1 is required for murine osteoblast differentiation and bone formation. Tang J; Xie J; Chen W; Tang C; Wu J; Wang Y; Zhou XD; Zhou HD; Li YP J Biol Chem; 2020 Aug; 295(33):11669-11681. PubMed ID: 32571873 [TBL] [Abstract][Full Text] [Related]
10. Osteoblast lineage-specific effects of notch activation in the skeleton. Canalis E; Parker K; Feng JQ; Zanotti S Endocrinology; 2013 Feb; 154(2):623-34. PubMed ID: 23275471 [TBL] [Abstract][Full Text] [Related]
11. Osteopenia and impaired fracture healing in aged EP4 receptor knockout mice. Li M; Healy DR; Li Y; Simmons HA; Crawford DT; Ke HZ; Pan LC; Brown TA; Thompson DD Bone; 2005 Jul; 37(1):46-54. PubMed ID: 15869929 [TBL] [Abstract][Full Text] [Related]
12. Osteopenia, decreased bone formation and impaired osteoblast development in Sox4 heterozygous mice. Nissen-Meyer LS; Jemtland R; Gautvik VT; Pedersen ME; Paro R; Fortunati D; Pierroz DD; Stadelmann VA; Reppe S; Reinholt FP; Del Fattore A; Rucci N; Teti A; Ferrari S; Gautvik KM J Cell Sci; 2007 Aug; 120(Pt 16):2785-95. PubMed ID: 17652162 [TBL] [Abstract][Full Text] [Related]
13. Skeletal characterization of an osteoblast-specific vitamin D receptor transgenic (ObVDR-B6) mouse model. Triliana R; Lam NN; Sawyer RK; Atkins GJ; Morris HA; Anderson PH J Steroid Biochem Mol Biol; 2016 Nov; 164():331-336. PubMed ID: 26343450 [TBL] [Abstract][Full Text] [Related]
14. Genetic deletion of CD36 enhances injury after acute neonatal stroke. Woo MS; Wang X; Faustino JV; Derugin N; Wendland MF; Zhou P; Iadecola C; Vexler ZS Ann Neurol; 2012 Dec; 72(6):961-70. PubMed ID: 23280844 [TBL] [Abstract][Full Text] [Related]
15. Anabolic action of parathyroid hormone is skeletal site specific at the tissue and cellular levels in mice. Iida-Klein A; Zhou H; Lu SS; Levine LR; Ducayen-Knowles M; Dempster DW; Nieves J; Lindsay R J Bone Miner Res; 2002 May; 17(5):808-16. PubMed ID: 12009011 [TBL] [Abstract][Full Text] [Related]
16. Reduced osteoblast activity in the mice lacking TR4 nuclear receptor leads to osteoporosis. Lin SJ; Ho HC; Lee YF; Liu NC; Liu S; Li G; Shyr CR; Chang C Reprod Biol Endocrinol; 2012 Jun; 10():43. PubMed ID: 22676849 [TBL] [Abstract][Full Text] [Related]
17. Skeletal development of mice lacking bone sialoprotein (BSP)--impairment of long bone growth and progressive establishment of high trabecular bone mass. Bouleftour W; Boudiffa M; Wade-Gueye NM; Bouët G; Cardelli M; Laroche N; Vanden-Bossche A; Thomas M; Bonnelye E; Aubin JE; Vico L; Lafage-Proust MH; Malaval L PLoS One; 2014; 9(5):e95144. PubMed ID: 24816232 [TBL] [Abstract][Full Text] [Related]
18. Matrix remodeling associated 7 promotes differentiation of bone marrow mesenchymal stem cells toward osteoblasts. Zhou Z; Shen Y; Yin J; Xi F; Xu R; Lin D; Saijilafu ; Chen J; Wang Y J Cell Physiol; 2019 Aug; 234(10):18053-18064. PubMed ID: 30843215 [TBL] [Abstract][Full Text] [Related]
19. Hematopoietic cell-restricted deletion of CD36 reduces high-fat diet-induced macrophage infiltration and improves insulin signaling in adipose tissue. Nicholls HT; Kowalski G; Kennedy DJ; Risis S; Zaffino LA; Watson N; Kanellakis P; Watt MJ; Bobik A; Bonen A; Febbraio M; Lancaster GI; Febbraio MA Diabetes; 2011 Apr; 60(4):1100-10. PubMed ID: 21378177 [TBL] [Abstract][Full Text] [Related]
20. Disruption of aldehyde dehydrogenase 2 gene results in altered cortical bone structure and increased cortical bone mineral density in the femoral diaphysis of mice. Tsuchiya T; Sakai A; Menuki K; Mori T; Takeuchi Y; Kanoh S; Utsunomiya H; Murai T; Isse T; Kawamoto T; Nakamura T Bone; 2013 Apr; 53(2):358-68. PubMed ID: 23313283 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]